An animal study by Zhu et al. demonstrated that, after acute middle cerebral artery occlusion, plasma syndecan-1 levels began to rise at 1 h, peaking at 6 h, gradually decreasing thereafter, and increasing again on days 5 and 7 (Zhu et al., 2021). The gene discussed is SDC1; the disease is medical procedure.